Clinical Trial

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine the effects of testosterone treatment on erectile function, fatigue, depression, cognitive function, quality of life, urinary incontinence, pain, and damage to neurons in male Multiple Sclerosis patients with low testosterone, using questionnaires, blood samples and a rectal exam in volunteers 55 years and older.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-10-19; most recent amendment 2025-08-28.
Trial Details
NCT Number NCT04601233
Lead Sponsor Tulane University
Collaborators: Louisiana State University Health Sciences Center in New Orleans, Antares Pharma Inc.
Conditions Multiple Sclerosis, Erectile Dysfunction, Testosterone Deficiency
Enrollment 20 participants
Start Date 2026-06
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-29